Differences between the medications Wegovy is a weight loss medication to help those with high BMIs lose weight, whilst the official use of Mounjaro is type 2 diabetes
In this survey, patients were asked to rate 54 symptoms, and based on their responses we characterized them into 6 groups: fatigue (I), malaise (II), sleep difficulties (III), pain (IV), cognitive/neurological manifestations (V), and other (VI) which included autonomic, neuroendocrine, and immune manifestations
the trials escalated deliberately, and the tolerability data is the reason
This drugs potential to simulate the effects of gastric bypass surgery could revolutionize obesity treatment, providing a valuable tool for those struggling with severe obesity and related health conditions
It is important to note that no universal definition of clinically significant weight regain exists
124, 1020 Bhattacha, S